Investing.com - Grifols ADR reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Grifols ADR announced earnings per share of $0.2786 on revenue of $1.6B. Analysts polled by Investing.com anticipated EPS of $0.2608 on revenue of $1.54B.
Grifols ADR shares are up 6% from the beginning of the year, still down 23.47% from its 52 week high of $20.49 set on January 19. They are under-performing the CAC 40 which is up 19.61% from the start of the year.
Grifols ADR shares gained 2.48% in intra-day trade following the report.
Grifols ADR follows other major Healthcare sector earnings this month
Grifols ADR's report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar